ADE number doubles in seven years
The number of adverse drug events reported to the FDA has doubled in the past seven years.
The number of serious adverse drug events occurring between 1998 and 2005 has more than doubled, according to a new report published in the Sept. 10 Archives of Internal Medicine. There were also twice as many ADE-related deaths reported during the same time period. The new information is based on the number of reports voluntarily submitted to the FDA through its Adverse Event Reporting System (AERS). A total of 467,809 serious events were associated with 1,489 drugs, but just 51 drugs were responsible for 43.6% of the reports and each had 500 or more reports associated with its use. The authors said the increase in ADE was four times faster than the growth in the total outpatient prescriptions in the U.S. during the same period and called the findings a serious public health problem.
Click here to see more articles from Drug Topics Daily News.
To go to the Drug Topics homepage, click here.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
